Mangalam Drugs and Organics share news, announcements and annual reports
NSE: MANGALAMBSE: 532637Pharmaceuticals & BiotechnologySmall Cap
Mangalam Drugs and Organics Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 2005
Last close ₹28.61down ₹0.61 (2.09%)BSE ₹28.92
Share price at the NSE close on 30 Oct 2026. Previous close ₹29.22.
30 Oct: open ₹29.48, high ₹29.75, low ₹28.51
52-week range of traded prices to 30 Oct 2026
₹22.80Low, 29 Dec 2025₹68.40High, 30 Oct 2025
- Under NSE's long-term additional surveillance, stage I, on the list for 30 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Next results date: the board meets on 5 Nov 2026 to consider: financial results and other business matters. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹45 Cr3,423rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.44
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −30.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −12.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 1.02
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 50,07391.9% delivered
Mangalam Drugs and Organics results
72 filed, newest first. Page 2 of 2.
Jan 2015
Nov 2014
Aug 2014
May 2014
29 May · Results
Feb 2014
13 Feb · Results
Nov 2013
12 Nov · Results
Aug 2013
May 2013
23 May · Results
Feb 2013
Nov 2012
Aug 2012
Jul 2012
23 Jul · Results
May 2012
21 May · Results
Feb 2012
Aug 2011
12 Aug · Results
Feb 2011
Nov 2010
May 2010
7 May · Results
The Company will publish the Audited Financial Results for the financial year ended March 31, 2010 on or before May 31, 2010 instead of publishing unaudited Financial Results for the quarter ended March 31, 2010.
Apr 2009
23 Apr · Results
Company will publish the Audited Financial Results for the financial year ended March 31, 2009 on or before June 30, 2009 instead of publishing unaudited Financial Results for the quarter ended March 31, 2009.
Apr 2008
22 Apr · Results
Company will publish the audited financial results for the quarter and year ended March 31, 2008 on or before June 30, 2008 instead of publishing unaudited Financial Results for the said period.
Apr 2007
20 Apr · Results
Company shall publish Audited Financial Results within a period of 3 month for the year ended on March 31, 2007 i.e. on or before June 30, 2007.
Feb 2007
1 Feb · Results
The Chairman of the Company announced the results of the Postal Ballot conducted by it pursuant to the Notice to the shareholders dated December 18, 2006 on February 1, 2007. The results are as under :- (1) Ordinary Resolution to accord the consent of the Company for Increase in Authorised Share Capital of the Company from Rs 14 crores to Rs. 20 crores and Alteration of the Memorandum of Association of the Company has been approved with the requisite majority. (2) Special Resolution pursuant to the provisions of Section 31 of the Companies Act, 1956, to accord the consent of the Company for Alteration of Articles of Association of the Company with respect to capital clause has been disapproved by the shareholders. (3) Special Resolution pursuant to the provisions of Section 31 of the Companies Act, 1956, to accord the consent of the Company for Alteration of Articles of Association of the Company with respect to Alteration of Article 83 has been disapproved by the shareholders.